Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Alzheimer Disease: HELP
Per Nilsson
Based on 11 articles published since 2010
(Why 11 articles?)
||||
Expertise Level
The expertise of Per Nilsson ranks in the
  • Top 0.75%
  • ... of 135,371 published authors worldwide on Alzheimer Disease
  • ... from 2010 through 2020
  • ... based on contributions to 11 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    RIKEN Wako      
2017
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Japan · Department of Neurology and Neurological Science, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan. · Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Japan. · Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Huddinge, Sweden. · Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan. · Dementia Research Institute, University College London, London, UK. · Department for Neurosciences, KU Leuven, Leuven, Belgium. · VIB Center for Brain and Disease Research, Leuven, Belgium. · Reta Lila Research Laboratories and the Department of Molecular Neuroscience, University College London Institute of Neurology, London, UK. · Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Pubmed 28768718
2015
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Saitama, Japan. · Karolinska Institutet, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Division for Neurogeriatrics, Huddinge, Sweden. · Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. · Dept of Biotechnology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan. · Pubmed 26194619
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Saitama, Japan; Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden. Electronic address: · Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Saitama, Japan. · Support Unit for Animal Resources Development, RIKEN Brain Science Institute, Wako, Saitama, Japan. · Department of Cell Biology, Unit of Basic Medical Sciences, Nagasaki University, Nagasaki, Japan. · Laboratory for Protein Conformation Diseases, RIKEN Brain Science Institute, Wako, Saitama, Japan. · Department of Biotechnology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan. · Pubmed 25433221
2014
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Saitama, Japan; KI-Alzheimer's Disease Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Novum, Huddinge, Sweden. · Pubmed 24711225
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute , 2-1 Hirosawa, Wako, Saitama 351-0198, Japan. · Pubmed 24852598
  • 1] Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan. [2] Japan Science and Technology Agency, Saitama, Japan. · Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan. · Laboratory for Behavioral Genetics, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan. · 1] Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan. [2] Department of Molecular Medicinal Sciences, Division of Biotechnology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. · Pubmed 24728269
2013
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan. Electronic address: · Pubmed 24095740
2010
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan. · Pubmed 20158567
2013
  • Bioengineering Laboratory, RIKEN , 2-1 Hirosawa, Wako, Saitama 351-0198, Japan. · Pubmed 23614719
2012
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan. · Pubmed 22767595
2011
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan. · Pubmed 21725313
Probable:    Karolinska Institute      
2017
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Japan · Department of Neurology and Neurological Science, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan. · Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Japan. · Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Huddinge, Sweden. · Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan. · Dementia Research Institute, University College London, London, UK. · Department for Neurosciences, KU Leuven, Leuven, Belgium. · VIB Center for Brain and Disease Research, Leuven, Belgium. · Reta Lila Research Laboratories and the Department of Molecular Neuroscience, University College London Institute of Neurology, London, UK. · Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Pubmed 28768718
2015
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Saitama, Japan. · Karolinska Institutet, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Division for Neurogeriatrics, Huddinge, Sweden. · Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. · Dept of Biotechnology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan. · Pubmed 26194619
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Saitama, Japan; Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden. Electronic address: · Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Saitama, Japan. · Support Unit for Animal Resources Development, RIKEN Brain Science Institute, Wako, Saitama, Japan. · Department of Cell Biology, Unit of Basic Medical Sciences, Nagasaki University, Nagasaki, Japan. · Laboratory for Protein Conformation Diseases, RIKEN Brain Science Institute, Wako, Saitama, Japan. · Department of Biotechnology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan. · Pubmed 25433221
2014
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Saitama, Japan; KI-Alzheimer's Disease Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Novum, Huddinge, Sweden. · Pubmed 24711225
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 11 total) written by Per Nilsson about Alzheimer Disease:

  • APP mouse models for Alzheimer's disease preclinical studies. 2017
  • Loss of neprilysin alters protein expression in the brain of Alzheimer's disease model mice. 2015
  • Autophagy-related protein 7 deficiency in amyloid β (Aβ) precursor protein transgenic mice decreases Aβ in the multivesicular bodies and induces Aβ accumulation in the Golgi. 2015
  • Dual roles for autophagy: degradation and secretion of Alzheimer's disease Aβ peptide. 2014
  • New mouse model of Alzheimer's. 2014
  • Single App knock-in mouse models of Alzheimer's disease. 2014
  • Aβ secretion and plaque formation depend on autophagy. 2013
  • Human prefoldin inhibits amyloid-β (Aβ) fibrillation and contributes to formation of nontoxic Aβ aggregates. 2013
  • Cell surface expression of the major amyloid-β peptide (Aβ)-degrading enzyme, neprilysin, depends on phosphorylation by mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK) and dephosphorylation by protein phosphatase 1a. 2012
  • Potent amyloidogenicity and pathogenicity of Aβ43. 2011
Show List of Full Article Records
Google Searches

Learn more about Per Nilsson using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
RIKEN Wako
Karolinska Institute
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
RIKEN Wako
2017
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Japan · Department of Neurology and Neurological Science, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan. · Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Japan. · Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Huddinge, Sweden. · Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan. · Dementia Research Institute, University College London, London, UK. · Department for Neurosciences, KU Leuven, Leuven, Belgium. · VIB Center for Brain and Disease Research, Leuven, Belgium. · Reta Lila Research Laboratories and the Department of Molecular Neuroscience, University College London Institute of Neurology, London, UK. · Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Pubmed 28768718
2015
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Saitama, Japan. · Karolinska Institutet, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Division for Neurogeriatrics, Huddinge, Sweden. · Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. · Dept of Biotechnology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan. · Pubmed 26194619
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Saitama, Japan; Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden. Electronic address: · Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Saitama, Japan. · Support Unit for Animal Resources Development, RIKEN Brain Science Institute, Wako, Saitama, Japan. · Department of Cell Biology, Unit of Basic Medical Sciences, Nagasaki University, Nagasaki, Japan. · Laboratory for Protein Conformation Diseases, RIKEN Brain Science Institute, Wako, Saitama, Japan. · Department of Biotechnology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan. · Pubmed 25433221
2014
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Saitama, Japan; KI-Alzheimer's Disease Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Novum, Huddinge, Sweden. · Pubmed 24711225
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute , 2-1 Hirosawa, Wako, Saitama 351-0198, Japan. · Pubmed 24852598
  • 1] Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan. [2] Japan Science and Technology Agency, Saitama, Japan. · Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan. · Laboratory for Behavioral Genetics, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan. · 1] Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan. [2] Department of Molecular Medicinal Sciences, Division of Biotechnology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. · Pubmed 24728269
2013
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan. Electronic address: · Pubmed 24095740
2010
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan. · Pubmed 20158567
2013
  • Bioengineering Laboratory, RIKEN , 2-1 Hirosawa, Wako, Saitama 351-0198, Japan. · Pubmed 23614719
2012
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan. · Pubmed 22767595
2011
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako-shi, Saitama, Japan. · Pubmed 21725313
Karolinska Institute
2017
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Japan · Department of Neurology and Neurological Science, Graduate School of Medicine, Tokyo Medical and Dental University, Tokyo, Japan. · Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Japan. · Division of Neurogeriatrics, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Huddinge, Sweden. · Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Nagoya, Japan. · Dementia Research Institute, University College London, London, UK. · Department for Neurosciences, KU Leuven, Leuven, Belgium. · VIB Center for Brain and Disease Research, Leuven, Belgium. · Reta Lila Research Laboratories and the Department of Molecular Neuroscience, University College London Institute of Neurology, London, UK. · Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Pubmed 28768718
2015
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Saitama, Japan. · Karolinska Institutet, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Division for Neurogeriatrics, Huddinge, Sweden. · Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. · Dept of Biotechnology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan. · Pubmed 26194619
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Saitama, Japan; Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden. Electronic address: · Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Saitama, Japan. · Support Unit for Animal Resources Development, RIKEN Brain Science Institute, Wako, Saitama, Japan. · Department of Cell Biology, Unit of Basic Medical Sciences, Nagasaki University, Nagasaki, Japan. · Laboratory for Protein Conformation Diseases, RIKEN Brain Science Institute, Wako, Saitama, Japan. · Department of Biotechnology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan. · Pubmed 25433221
2014
  • Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Wako, Saitama, Japan; KI-Alzheimer's Disease Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Novum, Huddinge, Sweden. · Pubmed 24711225
Yearly article counts 00010232111
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.